-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PlRMC63qka58muGGRMSnMD3/4O3qREl3sExXGpOrHTa5Y7NbxRzQ8O7hd/dwXBrG ctYByLP6BVeDQHn2H/kd1w== 0001209191-05-061323.txt : 20051205 0001209191-05-061323.hdr.sgml : 20051205 20051205210937 ACCESSION NUMBER: 0001209191-05-061323 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20051202 FILED AS OF DATE: 20051205 DATE AS OF CHANGE: 20051205 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENDO PHARMACEUTICALS HOLDINGS INC CENTRAL INDEX KEY: 0001100962 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 134022871 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ENDO BOULEVARD CITY: CHADDS FORD STATE: PA ZIP: 19317 BUSINESS PHONE: 6105589800 MAIL ADDRESS: STREET 1: 100 ENDO BOULEVARD CITY: CHADDS FORD STATE: PA ZIP: 19317 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KELSO PARTNERS V L P CENTRAL INDEX KEY: 0001045750 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15989 FILM NUMBER: 051245734 BUSINESS ADDRESS: STREET 1: C/O KELSO & CO STREET 2: 350 PARK AVENUE 24TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2127513939 MAIL ADDRESS: STREET 1: C/O KELSO & CO STREET 2: 350 PARK AVENUE 24TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2005-12-02 0 0001100962 ENDO PHARMACEUTICALS HOLDINGS INC ENDP 0001045750 KELSO PARTNERS V L P 320 PARK AVENUE NEW YORK NY 10022 0 0 1 0 Common Stock, par value $.01 per share 2005-12-02 4 X 0 4646 2.42 D 15799133 I By Endo Pharma LLC Common Stock, par value $.01 per share 2005-12-02 4 X 0 381 2.42 D 15798753 I By Endo Pharma LLC Common Stock, par value $.01 per share 2005-12-02 4 X 0 1626 2.42 D 15797127 I By Endo Pharma LLC Common Stock, par value $.01 per share 2005-12-02 4 X 0 578 2.42 D 15796548 I By Endo Pharma LLC Common Stock, par value $.01 per share 2005-12-02 4 X 0 2448 2.42 D 15794100 I By Endo Pharma LLC Common Stock, par value $.01 per share 2005-12-02 4 X 0 470 3.00 D 15793631 I By Endo Pharma LLC Common Stock, par value $.01 per share 2005-12-02 4 X 0 1321 3.00 D 15792309 I By Endo Pharma LLC Common Stock, par value $.01 per share 2005-12-02 4 X 0 394 3.00 D 15791915 I By Endo Pharma LLC Common Stock, par value $.01 per share 2005-12-02 4 X 0 102 3.00 D 15791814 I By Endo Pharma LLC Call Option (obligation to sell) 2.42 2005-12-02 4 X 0 4646 2.42 D 2005-10-13 2007-08-26 Common Stock 4646 1020551 I By Endo Pharma LLC Call Option (obligation to sell) 2.42 2005-12-02 4 X 0 381 2.42 D 2005-10-13 2007-08-26 Common Stock 381 1168531 I By Endo Pharma LLC Call Option (obligation to sell) 2.42 2005-12-02 4 X 0 1626 2.42 D 2005-10-13 2007-08-26 Common Stock 1626 23886 I By Endo Pharma LLC Call Option (obligation to sell) 2.42 2005-12-02 4 X 0 578 2.42 D 2005-10-13 2007-08-26 Common Stock 578 8181 I By Endo Pharma LLC Call Option (obligation to sell) 2.42 2005-12-02 4 X 0 2448 2.42 D 2005-10-13 2007-08-26 Common Stock 2448 27191 I By Endo Pharma LLC Call Option (obligation to sell) 3.00 2005-12-02 4 X 0 470 3.00 D 2005-10-13 2007-08-26 Common Stock 470 3318 I By Endo Pharma LLC Call Option (obligation to sell) 3.00 2005-12-02 4 X 0 1321 3.00 D 2005-10-13 2007-08-26 Common Stock 1321 257489 I By Endo Pharma LLC Call Option (obligation to sell) 3.00 2005-12-02 4 X 0 394 3.00 D 2005-10-13 2007-08-26 Common Stock 394 663 I By Endo Pharma LLC Call Option (obligation to sell) 3.00 2005-12-02 4 X 0 102 3.00 D 2005-10-13 2007-08-26 Common Stock 102 20939 I By Endo Pharma LLC Kelso Partners V, L.P. (KP V") is the designated filer. KP V may be deemed to share beneficial ownership of shares of Common Stock owned of record by Endo Pharma LLC by virtue of its status as a member of Endo Pharma LLC. KP V shares investment and voting power along with the other members of Endo Pharma LLC with respect to secutieties owned by Endo Pharma LLC, but disclaims beneficial ownership of such securities except to the extent of its pecuniary interest. Each individual reporting person may be deemed to share beneficial ownership of shares of Common Stock owned of record by KP V, by virtue of his status as a general partner of the general partner of KP V, and each individual shares investment and voting power along with the other general partners of KP V, but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest. James J. Connors II 2005-12-05 EX-24.4_111427 2 poa.txt POA DOCUMENT LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS Know all by these present that each of the undersigned hereby makes, constitutes and appoints James J. Connors II, Howard A. Matlin and Rosanna T. Leone, and each of them, with full power of substitution and resubstitution, as such undersigned's true and lawful attorneys-in-fact, with full power and authority as hereinafter described on behalf of and in the name, place and stead of the undersigned to: (1) executed and deliver for and on behalf of the undersigned (i) any and all Forms 3, 4 and 5 relating to Endo Pharmaceuticals Holdings Inc., a Delaware corporation (the "Company") and required to be filed in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") and the rules thereunder and (ii) any and all schedules relating to the company required to be filed in accordance with Section 13(d) of the Exchange Act and the rules thereunder (together, the "Forms and Schedules"), in the undersigned's capacity as a director and/or controlling person of the Company and/or as an officer or general partner of Kelso Partners V, L.P., and/or Kelso Equity Partners V, L.P., and in and all other capacities pursuant to which such Forms and Schedules may be required to be filed by the undersigned; (2) do and perform any and all acts and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Forms and timely file such Forms and Schedules with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned acknowledges that: (1) this Power of Attorney authorizes, but does not require, such attorney-in-fact to act in their discretion on information provided to such attorney-in-fact without independent verification of such information; (2) any documents prepared and/or executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney will be in such form and will contain such information and disclosure as such attorney-in-fact, in his or her discretion, deems necessary or desirable; (3) neither the Company nor such attorney-in-fact assumes (i) any liability for the undersigned's responsibility to comply with the requirement of the Exchange Act, (ii) any liability of the undersigned for any failure to comply with such requirements, or (iii) any obligation or liability of the undersigned for profit disgorgement under Section 16(b) of the Exchange Act; and (4) this Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned's obligations under the Exchange Act, including without limitation the reporting requirements under Section 16 of the Exchange Act. The undersigned hereby gives and grants the foregoing attorney-in-fact full power and authority to do and perform all and every act and thing whatsoever requisite, necessary or appropriate to be done in and about the foregoing matters as fully to all intents and purposes as the undersigned might or could do if present, hereby ratifying all that such attorney-in-fact of, for an on behalf of he undersigned, shall lawfully do or cause to be done by virtue of this Limited Power of Attorney. This Power of Attorney shall remain in full force and effect until revoked by the undersigned in a signed writing delivered to such attorney-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 11th day of August, 2004. KELSO INVESTMENT ASSOCIATES V, L.P. By: Kelso Partners V, L.P., its General Partner By: /s/ George E. Matelich KELSO EQUITY PARTNERS V, L.P. By: /s/ George E. Matelich KELSO PARTNERS V, L.P. By: /s/ George E. Matelich /s/ Philip E. Berney Philip E. Berney /s/ Frank K. Bynum, Jr. Frank K. Bynum, Jr. /s/ Michael B. Goldberg Michael B. Goldberg /s/ Michael B. Lazar Michael B. Lazar /s/ Frank J. Loverro Frank J. Loverro /s/ George E. Matelich George E. Matelich /s/ Frank T. Nickell Frank T. Nickell /s/ Joseph S. Schuchert Joseph S. Schuchert /s/ David I. Wahrhaftig David I. Wahrhaftig /s/ Thomas R. Wall, IV Thomas R. Wall, IV STATE OF NEW YORK COUNTY OF NEW YORK On this 11th day of August, 2004, the individuals set forth on the attached Schedule A personally appeared before me, and acknowledged that s/he executed the foregoing instrument for the purposes therein contained. IN WITNESS WHEREOF, I have hereunto set my hand and official seal. /s/ Cheryl A. Gardiner Notary Public Notary Public, State of New York No. 41-4873823 My Commission Expires: 10/14/06 Schedule A Philip E. Berney, as the General Partner of Kelso Partners V, L.P. and Kelso Equity Partners V, L.P. Philip E. Berney Frank K. Bynum, Jr. Michael B. Goldberg Michael B. Lazar Frank J. Loverro George E. Matelich Frank T. Nickell Joseph S. Schuchert David I. Wahrhaftig Thomas R. Wall, IV -----END PRIVACY-ENHANCED MESSAGE-----